AxoGen PE Ratio 2010-2024 | AXGN
Current and historical p/e ratio for AxoGen (AXGN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. AxoGen PE ratio as of May 09, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| AxoGen PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-09 | 11.37 | 0.00 | |
| 2024-12-31 | 16.48 | $-0.22 | 0.00 |
| 2024-09-30 | 14.02 | $-0.32 | 0.00 |
| 2024-06-30 | 7.24 | $-0.38 | 0.00 |
| 2024-03-31 | 8.07 | $-0.50 | 0.00 |
| 2023-12-31 | 6.83 | $-0.52 | 0.00 |
| 2023-09-30 | 5.00 | $-0.56 | 0.00 |
| 2023-06-30 | 9.13 | $-0.56 | 0.00 |
| 2023-03-31 | 9.45 | $-0.58 | 0.00 |
| 2022-12-31 | 9.98 | $-0.68 | 0.00 |
| 2022-09-30 | 11.92 | $-0.68 | 0.00 |
| 2022-06-30 | 8.19 | $-0.75 | 0.00 |
| 2022-03-31 | 7.94 | $-0.76 | 0.00 |
| 2021-12-31 | 9.37 | $-0.65 | 0.00 |
| 2021-09-30 | 15.80 | $-0.67 | 0.00 |
| 2021-06-30 | 21.61 | $-0.54 | 0.00 |
| 2021-03-31 | 20.26 | $-0.55 | 0.00 |
| 2020-12-31 | 17.90 | $-0.60 | 0.00 |
| 2020-09-30 | 11.63 | $-0.63 | 0.00 |
| 2020-06-30 | 9.24 | $-0.73 | 0.00 |
| 2020-03-31 | 10.40 | $-0.71 | 0.00 |
| 2019-12-31 | 17.89 | $-0.74 | 0.00 |
| 2019-09-30 | 12.48 | $-0.69 | 0.00 |
| 2019-06-30 | 19.80 | $-0.66 | 0.00 |
| 2019-03-31 | 21.06 | $-0.68 | 0.00 |
| 2018-12-31 | 20.43 | $-0.60 | 0.00 |
| 2018-09-30 | 36.85 | $-0.54 | 0.00 |
| 2018-06-30 | 50.25 | $-0.49 | 0.00 |
| 2018-03-31 | 36.50 | $-0.35 | 0.00 |
| 2017-12-31 | 28.30 | $-0.30 | 0.00 |
| 2017-09-30 | 19.35 | $-0.40 | 0.00 |
| 2017-06-30 | 16.75 | $-0.42 | 0.00 |
| 2017-03-31 | 10.45 | $-0.45 | 0.00 |
| 2016-12-31 | 9.00 | $-0.46 | 0.00 |
| 2016-09-30 | 9.03 | $-0.41 | 0.00 |
| 2016-06-30 | 6.88 | $-0.44 | 0.00 |
| 2016-03-31 | 5.36 | $-0.48 | 0.00 |
| 2015-12-31 | 5.00 | $-0.52 | 0.00 |
| 2015-09-30 | 4.12 | $-0.76 | 0.00 |
| 2015-06-30 | 3.14 | $-0.84 | 0.00 |
| 2015-03-31 | 3.50 | $-0.92 | 0.00 |
| 2014-12-31 | 3.59 | $-1.00 | 0.00 |
| 2014-09-30 | 2.44 | $-0.88 | 0.00 |
| 2014-06-30 | 2.78 | $-0.94 | 0.00 |
| 2014-03-31 | 3.05 | $-1.04 | 0.00 |
| 2013-12-31 | 4.49 | $-1.11 | 0.00 |
| 2013-09-30 | 4.44 | $-1.23 | 0.00 |
| 2013-06-30 | 4.34 | $-1.18 | 0.00 |
| 2013-03-31 | 3.61 | $-0.96 | 0.00 |
| 2012-12-31 | 2.70 | $-0.84 | 0.00 |
| 2012-09-30 | 2.70 | $-0.48 | 0.00 |
| 2012-06-30 | 3.00 | $-2.88 | 0.00 |
| 2012-03-31 | 2.70 | $-2.73 | 0.00 |
| 2011-12-31 | 2.70 | $-2.33 | 0.00 |
| 2011-09-30 | 2.50 | $-2.42 | 0.00 |
| 2011-06-30 | 3.00 | $0.07 | 42.86 |
| 2011-03-31 | 2.75 | $-0.04 | 0.00 |
| 2010-12-31 | 3.49 | $-0.31 | 0.00 |
| 2010-09-30 | 3.50 | $-0.22 | 0.00 |
| 2010-06-30 | 2.99 | $-0.11 | 0.00 |
| 2010-03-31 | 3.10 | $-0.06 | 0.00 |
| 2009-12-31 | 3.38 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.518B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.295B | 84.22 |
| Thermo Fisher Scientific (TMO) | United States | $152.179B | 18.41 |
| Alcon (ALC) | Switzerland | $47.228B | 31.39 |
| Edwards Lifesciences (EW) | United States | $43.221B | 28.34 |
| IDEXX Laboratories (IDXX) | United States | $39.544B | 45.44 |
| DexCom (DXCM) | United States | $33.200B | 51.32 |
| IQVIA Holdings (IQV) | United States | $25.775B | 14.44 |
| Mettler-Toledo (MTD) | United States | $22.466B | 26.72 |
| STERIS (STE) | Ireland | $22.247B | 25.44 |
| Waters (WAT) | United States | $20.475B | 28.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.744B | 0.00 |
| Hologic (HOLX) | United States | $12.646B | 13.74 |
| Penumbra (PEN) | United States | $11.514B | 90.37 |
| Sysmex ADR (SSMXY) | Japan | $11.482B | 0.00 |
| Masimo (MASI) | United States | $8.489B | 31.31 |
| Globus Medical (GMED) | United States | $7.678B | 18.01 |
| Teleflex (TFX) | United States | $5.528B | 9.13 |
| Glaukos (GKOS) | United States | $5.140B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.133B | 21.65 |
| TransMedics (TMDX) | United States | $3.771B | 81.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.327B | 32.65 |
| Nihon Kohden (NHNKY) | Japan | $2.040B | 11.15 |
| Elekta AB (EKTAY) | Sweden | $1.943B | 17.47 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.531B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.952B | 5.06 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.673B | 14.71 |
| IRadimed (IRMD) | United States | $0.659B | 33.46 |
| Beta Bionics (BBNX) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.10 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| RxSight (RXST) | United States | $0.531B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.473B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.422B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.09 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.222B | 13.44 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.201B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.159B | 0.00 |
| Accuray (ARAY) | United States | $0.156B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.22 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.64 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |